French pharma SaaS startup Biolevate raised a €30M Series A co-led by RAISE France and Orange Ventures, taking its total funding to €36M — Biolevate, a French pharma-focused SaaS startup, raised €30 million in Series A funding, CEO Joël Belafa tells Axios Pro exclusively.
Posted from: this blog via Microsoft Power Automate.